Northern Trust’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Sell |
|
|||||
|
2025
Q1 | $1.39M | Sell |
|
|||||
|
2024
Q4 | $2.37M | Buy |
|
|||||
|
2024
Q3 | $2.38M | Buy |
|
|||||
|
2024
Q2 | $2.96M | Sell |
|
|||||
|
2024
Q1 | $3.63M | Buy |
|
|||||
|
2023
Q4 | $2.66M | Buy |
|
|||||
|
2023
Q3 | $2.35M | Buy |
|
|||||
|
2023
Q2 | $3.39M | Buy |
|
|||||
|
2023
Q1 | $663K | Buy |
|
|||||
|
2022
Q4 | $510K | Buy |
|
|||||
|
2022
Q3 | $456K | Buy |
|
|||||
|
2022
Q2 | $442K | Sell |
|
|||||
|
2022
Q1 | $603K | Buy |
|
|||||
|
2021
Q4 | $209K | Buy |
|
|||||
|
2021
Q3 | $197K | Sell |
|
|||||
|
2021
Q2 | $348K | Sell |
|
|||||
|
2021
Q1 | $1.47M | Sell |
|
|||||
|
2020
Q4 | $2.53M | Sell |
|
|||||
|
2020
Q3 | $3.86M | Sell |
|
|||||
|
2020
Q2 | $4.75M | Buy |
|
|||||
|
2020
Q1 | $3.15M | Buy |
|
|||||
|
2019
Q4 | $4.68M | Sell |
|
|||||
|
2019
Q3 | $5.78M | Buy |
|
|||||
|
2019
Q2 | $8.05M | Buy |
|
|||||
|
2019
Q1 | $5.37M | Buy |
|
|||||
|
2018
Q4 | $2.58M | Sell |
|
|||||
|
2018
Q3 | $5.39M | Buy |
|
|||||
|
2018
Q2 | $5.23M | Buy |
|
|||||
|
2018
Q1 | $3.77M | Buy |
|
|||||
|
2017
Q4 | $3.22M | Buy |
|
|||||
|
2017
Q3 | $3.16M | Buy |
|
|||||
|
2017
Q2 | $1.2M | Buy |
|
|||||
|
2017
Q1 | $1.4M | Sell |
|
|||||
|
2016
Q4 | $1.35M | Buy |
|
|||||
|
2016
Q3 | $1.27M | Sell |
|
|||||
|
2016
Q2 | $1.16M | Buy |
|
|||||
|
2016
Q1 | $480K | Hold |
|
|||||
|
2015
Q4 | $1.2M | Buy |
|